The Role of Amino Acid Starvation Response Kinase GCN2 in Abdominal Aortic Aneurysm
氨基酸饥饿反应激酶 GCN2 在腹主动脉瘤中的作用
基本信息
- 批准号:10584543
- 负责人:
- 金额:$ 40.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:Abdominal Aortic AneurysmAdoptedAmericanAmino AcidsAngiotensin IIAortaArginineArginine deiminaseAutomobile DrivingBiologicalBiological AssayCaloric RestrictionCardiovascular DiseasesCell SurvivalCellsClinicalClinical ManagementCo-ImmunoprecipitationsCytoprotectionDevelopmentDiameterDietary InterventionDiseaseElastasesElderlyExhibitsFunctional disorderGenderGenetic TranscriptionHealthHealth BenefitHomeostasisHumanIn VitroInflammatoryInterventionIntervention StudiesKnock-outKnockout MiceLeadLesionLeucineLifeMediatingMedicalMetabolic stressMethionineModelingMolecularMusMutationNewly DiagnosedOperative Surgical ProceduresOutcomeParacrine CommunicationPathogenesisPatientsPharmaceutical PreparationsPharmacotherapyPhenotypePhosphotransferasesPilot ProjectsPlayPopulationPost-Translational Protein ProcessingPreventionProteinsRattusRecombinant ProteinsRegulationRepressionResistanceRisk ReductionRodentRoleRuptureSignal TransductionSmooth Muscle MyocytesSpecimenStarvationTestingTherapeuticTimeTransgenic OrganismsVascular Smooth Muscleabdominal aortaactivating transcription factor 3combatcostdietarydietary restrictioneffective interventioneffective therapygain of functionin vivoinnovationknock-downloss of functionmortalitymulti-ethnicmutantnovelpreventrepairedresponsescreeningstress kinasesuccesstranscription factor
项目摘要
Project Summary: Abdominal aortic aneurysm (AAA) is a life-threatening disease that afflicts ~1.5 million
Americans, particularly in the elderly populations. Despite its high mortality (80-90%) upon rupture, there is a
lack of effective drug therapies for clinical management of AAA. Surgical repairs remain the only effective
options; however, not only are they considered traumatic and risky, but also not indicated for the majority of
newly diagnosed AAA patients. Therefore, there is a pressing unmet need to develop non-surgical strategies to
contain AAA progression. Dietary restrictions of amino acids emerge as promising avenues to combat
cardiovascular diseases. For the first time, our study demonstrated the potential of dietary methionine or
leucine restrictions in inhibiting the development of AAA in a rat model. It is well established that such dietary
restrictions trigger the amino acid starvation response, a potent protective mechanism driven by the metabolic
stress kinase general control nondepressible 2 (GCN2). Indeed, in our preliminary study, silencing GCN2 in rat
abdominal aorta nullified the benefits of methionine restriction against AAA, suggesting a protective role of
GCN2 in reinstating aortic homeostasis. Activating GCN2 through methionine restriction protected smooth
muscle cells (SMCs) from undergoing degeneration, which is one of the key determinants of AAA
pathogenesis; conversely, reduced GCN2 activity was robustly observed in clinical specimens of AAA, and
GCN2 silencing effectively compromised the protection against SMC degeneration. Finally, we serendipitously
identified GCN2 to be citrullinated by peptidyl arginine deiminase 3 (PADI3) at its 1475 arginine (R1475)
residue in the starvation-sensing domain. This post-translational modification (PTM) of GCN2 was increased in
AAA and correlated with repressed GCN2 activity. Collectively, these preliminary results lead to our central
hypothesis: GCN2 plays a pivotal role in protecting against SMC degeneration and AAA formation, and its
activity is negatively modulated by PADI3-mediated citrullination; GCN2-activating strategies offer a new
paradigm for effective prevention and intervention of AAA. In Aim 1, we will dissect the role of GCN2 in
safeguarding SMC homeostasis as well as its downstream signaling using human and murine SMCs. In Aim 2,
we will characterize a new PTM regulation that negatively modulates GCN2 activity and delineate the biological
consequences of GCN2 citrullination in SMC. In Aim 3, we will determine the mechanistic and therapeutic
implications of GCN2 activation in AAA, utilizing both transgenic (SMC-specific GCN2 knockout mice) and
dietary intervention approaches (methionine restriction for treatment of pre-existing AAA lesions). The
successful completion of the proposed studies will not only uncover an intrinsic protective mechanism against
SMC degeneration and AAA pathogenesis, but also may provide a new paradigm through GCN2-activating
dietary restrictions for effective prevention and intervention of AAA.
项目摘要:腹部主动脉瘤(AAA)是一种威胁生命的疾病,遭受约150万
美国人,特别是在老年人中。尽管破裂时死亡率很高(80-90%),但仍有一个
缺乏用于AAA临床管理的有效药物疗法。手术维修仍然是唯一有效的
选项;但是,它们不仅被认为是创伤和冒险的,而且并未指出大多数
新诊断为AAA患者。因此,有迫切需要制定非手术策略
包含AAA进展。出现氨基酸的饮食限制是应对有前途的途径
心血管疾病。我们的研究首次证明了饮食中蛋氨酸或
亮氨酸限制在大鼠模型中抑制AAA的发展。众所周知,这种饮食
限制触发氨基酸饥饿反应,这是由代谢驱动的有效保护机制
应力激酶一般对照非抑制2(GCN2)。实际上,在我们的初步研究中,将大鼠沉默的GCN2沉默
腹主动脉无效甲硫氨酸对AAA的好处,这表明保护作用
GCN2恢复主动脉稳态。通过蛋氨酸限制激活GCN2。
发生变性的肌肉细胞(SMC),这是AAA的关键决定因素之一
发病;相反,在AAA的临床标本中稳健观察到GCN2活性的降低,并且
GCN2沉默有效地损害了SMC变性的保护。最后,我们偶然地
鉴定出GCN2在其1475精氨酸(R1475)上被肽基精氨酸脱氨酶3(PADI3)固定
饥饿感应域中的残留物。 GCN2的这种翻译后修饰(PTM)在
AAA并与抑制GCN2活性相关。总的来说,这些初步结果导致了我们的中心
假设:GCN2在保护SMC变性和AAA形成及其ITS及其及其及其的作用方面起着关键作用
PADI3介导的柠檬酸化对活性进行负调节。 GCN2激活策略提供了新的
有效预防和干预AAA的范式。在AIM 1中,我们将剖析GCN2在
使用人和鼠SMC来保护SMC稳态及其下游信号。在AIM 2中,
我们将表征一种新的PTM调节,该调节对GCN2活性进行负面调节并描述生物学
SMC中GCN2鞭打的后果。在AIM 3中,我们将确定机械和治疗性
使用转基因(SMC特异性GCN2基因敲除小鼠)和
饮食干预方法(用于治疗预先存在的AAA病变的蛋氨酸限制)。这
成功完成拟议的研究不仅会发现一种固有的保护机制
SMC变性和AAA发病机理,但也可以通过GCN2激活提供新的范式
有效预防和干预AAA的饮食限制。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Dietary therapy in abdominal aortic aneurysm - Insights from clinical and experimental studies.
- DOI:10.3389/fcvm.2022.949262
- 发表时间:2022
- 期刊:
- 影响因子:3.6
- 作者:Yin, Li;Gregg, Alexander Christopher;Riccio, Alessandra Marie;Hoyt, Nicholas;Islam, Zain Hussain;Ahn, Jungeun;Le, Quang;Patel, Paranjay;Zhang, Mengxue;He, Xinran;McKinney, Matthew;Kent, Eric;Wang, Bowen
- 通讯作者:Wang, Bowen
Progress in murine models of ruptured abdominal aortic aneurysm.
- DOI:10.3389/fcvm.2022.950018
- 发表时间:2022
- 期刊:
- 影响因子:3.6
- 作者:Yin, Li;Kent, Eric William;Wang, Bowen
- 通讯作者:Wang, Bowen
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bowen Wang其他文献
Bowen Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bowen Wang', 18)}}的其他基金
The Role of Amino Acid Starvation Response Kinase GCN2 in Abdominal Aortic Aneurysm
氨基酸饥饿反应激酶 GCN2 在腹主动脉瘤中的作用
- 批准号:
10419309 - 财政年份:2022
- 资助金额:
$ 40.99万 - 项目类别:
相似国自然基金
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
破解老年人数字鸿沟:老年人采用数字技术的决策过程、客观障碍和应对策略
- 批准号:72303205
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
通过抑制流体运动和采用双能谱方法来改进烧蚀速率测量的研究
- 批准号:12305261
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
采用多种稀疏自注意力机制的Transformer隧道衬砌裂缝检测方法研究
- 批准号:62301339
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
政策激励、信息传递与农户屋顶光伏技术采用提升机制研究
- 批准号:72304103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Creation of a knowledgebase of high quality assertions of the clinical actionability of somatic variants in cancer
创建癌症体细胞变异临床可行性的高质量断言知识库
- 批准号:
10555024 - 财政年份:2023
- 资助金额:
$ 40.99万 - 项目类别:
Paid Sick Leave Mandates and Mental Healthcare Service Use
带薪病假规定和心理保健服务的使用
- 批准号:
10635492 - 财政年份:2023
- 资助金额:
$ 40.99万 - 项目类别:
Clinical Feasibility of Wireless Catheter-Free Urodynamics for Extended, Comprehensive Urological Evaluation in the Home Setting
无线无导管尿动力学在家庭环境中进行扩展、综合泌尿外科评估的临床可行性
- 批准号:
10762486 - 财政年份:2023
- 资助金额:
$ 40.99万 - 项目类别:
Towards the understanding of how chaperones function and prevent amyloidogenic diseases
了解伴侣如何发挥作用并预防淀粉样蛋白形成疾病
- 批准号:
10734397 - 财政年份:2023
- 资助金额:
$ 40.99万 - 项目类别:
Development of Next-Generation Mass Spectrometry-based de novo RNA Sequencing for all Modifications
开发适用于所有修饰的下一代基于质谱的从头 RNA 测序
- 批准号:
10581994 - 财政年份:2023
- 资助金额:
$ 40.99万 - 项目类别: